{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:27:50Z","timestamp":1792207670548,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2019CXJQ02"],"award-info":[{"award-number":["2019CXJQ02"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870829"],"award-info":[{"award-number":["31870829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900102"],"award-info":[{"award-number":["31900102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M652792"],"award-info":[{"award-number":["2019M652792"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40995"],"award-info":[{"award-number":["2021JJ40995"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.omtn.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T02:36:40Z","timestamp":1657593400000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-662X","authenticated-orcid":false,"given":"Xingxing","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-2243","authenticated-orcid":false,"given":"Lu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.07.006_bib1","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1172\/JCI61188","article-title":"Molecular pathogenesis of multiple myeloma and its premalignant precursor","volume":"122","author":"Kuehl","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2022.07.006_bib2","first-page":"7","article-title":"Cancer statistics 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omtn.2022.07.006_bib3","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.7150\/thno.15584","article-title":"Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma","volume":"6","author":"Roy","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2022.07.006_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1878-0261.12641","article-title":"NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma","volume":"14","author":"Xia","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omtn.2022.07.006_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40168-020-00854-5","article-title":"Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria","volume":"8","author":"Jian","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.omtn.2022.07.006_bib6","doi-asserted-by":"crossref","first-page":"e2104491","DOI":"10.1002\/advs.202104491","article-title":"Genetic aberrations and interaction of NEK2 and TP53 accelerate aggressiveness of multiple myeloma","volume":"9","author":"Feng","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2022.07.006_bib7","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtn.2022.07.006_bib8","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtn.2022.07.006_bib9","first-page":"e4508794","article-title":"Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates","volume":"2019","author":"Sambi","year":"2019","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.omtn.2022.07.006_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.07.006_bib11","doi-asserted-by":"crossref","first-page":"672356","DOI":"10.3389\/fimmu.2021.672356","article-title":"Neoantigen: a new breakthrough in tumor immunotherapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.07.006_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2022.07.006_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12920-020-0683-4","article-title":"ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection","volume":"13","author":"Li","year":"2020","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.omtn.2022.07.006_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/genes13050783","article-title":"ProGeo-Neo v2.0: a one-stop software for neoantigen prediction and filtering based on the proteogenomics strategy","volume":"13","author":"Liu","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2022.07.006_bib15","doi-asserted-by":"crossref","first-page":"baaa004","DOI":"10.1093\/database\/baaa004","article-title":"dbPepNeo: a manually curated database for human tumor neoantigen peptides","volume":"2020","author":"Tan","year":"2020","journal-title":"Database"},{"key":"10.1016\/j.omtn.2022.07.006_bib16","doi-asserted-by":"crossref","first-page":"855976","DOI":"10.3389\/fimmu.2022.855976","article-title":"dbPepNeo2.0: a database for human tumor neoantigen peptides from mass spectrometry and TCR recognition","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.07.006_bib17","first-page":"441","article-title":"Advances in the prediction of antigenic peptides in personalized tumor neoantigen vaccine","volume":"46","author":"Wang","year":"2019","journal-title":"Prog. Biochem. Biophys."},{"key":"10.1016\/j.omtn.2022.07.006_bib18","first-page":"363","article-title":"Bioinformatics prediction of candidate epitopes for peptide vaccines based on pathogen antigenic protein sequences","volume":"25","author":"Zhao","year":"2021","journal-title":"Life Sci. Res."},{"key":"10.1016\/j.omtn.2022.07.006_bib19","doi-asserted-by":"crossref","first-page":"5798356","DOI":"10.1155\/2020\/5798356","article-title":"INeo-Epp: a novel T-cell HLA class-I immunogenicity or neoantigenic epitope prediction method based on sequence-related amino acid features","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtn.2022.07.006_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.07.006_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T\u00a0cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.07.006_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.07.006_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.07.006_bib24","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden-high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2022.07.006_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-018-0751-1","article-title":"The perfect personalized cancer therapy: cancer vaccines against neoantigens","volume":"37","author":"Aurisicchio","year":"2018","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2022.07.006_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2022.07.006_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-016-0264-5","article-title":"pVAC-Seq: a genome-guided in\u00a0silico approach to identifying tumor neoantigens","volume":"8","author":"Hundal","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.omtn.2022.07.006_bib28","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.07.006_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2020.08.019","article-title":"Immunogenomic landscape of hematological malignancies","volume":"38","author":"Dufva","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2022.07.006_bib30","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/s41467-020-19288-6","article-title":"Immune modulatory effects of oncogenic KRAS in cancer","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.07.006_bib31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41467-021-21736-w","article-title":"KRAS drives immune evasion in a genetic model of pancreatic cancer","volume":"12","author":"Ischenko","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.07.006_bib32","doi-asserted-by":"crossref","first-page":"jcs237453","DOI":"10.1242\/jcs.237453","article-title":"p53, cancer and the immune response","volume":"133","author":"Blagih","year":"2020","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.omtn.2022.07.006_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.07.006_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/1078-0432.CCR-19-2309","article-title":"Mutation-derived neoantigen-specific T-cell responses in multiple myeloma","volume":"26","author":"Perumal","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2022.07.006_bib35","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1038\/bcj.2017.94","article-title":"High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma","volume":"7","author":"Miller","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omtn.2022.07.006_bib36","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, Ido, and T(regs) in the melanoma tumor microenvironment is driven by CD8+ T\u00a0cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2022.07.006_bib37","doi-asserted-by":"crossref","first-page":"e002417","DOI":"10.1136\/jitc-2021-002417","article-title":"Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma","volume":"9","author":"Bao","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omtn.2022.07.006_bib38","first-page":"3360","article-title":"NetMHCpan 4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omtn.2022.07.006_bib39","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2022.07.006_bib40","doi-asserted-by":"crossref","first-page":"776997","DOI":"10.3389\/fonc.2021.776997","article-title":"Clinicopathological features combined with immune infiltration could well distinguish outcomes in stage II and stage III colorectal cancer: a retrospective study","volume":"11","author":"Ren","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:29:08Z","timestamp":1761874148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"alternative-id":["S2162253122001755"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.07.006","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}